Scholars Central

Conference abstractPublished 2015

Immortalization of human adipose-derived stromal cells as possible strategy to employ their paracrine characteristics in regenerative therapies

Authors: Luigi Balducci

Medestea Research & Production Laboratories, Italy

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Human adipose-derived stromal cells (hASCs) are feasibly isolated and expanded. In addition, it is well established that they secrete large amounts of growth factors. Several findings suggest that rather than trans-differentiation, hASCs could exert a therapeutic potential through a potent paracrine mechanism. All these features make hASCs a real and powerful therapeutic tool for the treatment of several human diseases. However, hASCs limited culture life-span can obstacle full employment of their paracrine characteristics in regenerative therapies. Under this perspective, hASCs immortalization may be a possible strategy to circumvent this problem. hASCs were immortalized by co-transducing human telomerase reverse transcriptase (hTERT) gene with either SV-40 or human papilloma virus (HPV) E6/E7 genes. Flow cytometry was assessed to analyze mesenchymal marker expression. Differentiation potential was evaluated by immunocytochemistry and the levels of two cytokines, HGF and VEGF were assayed by ELISA. Finally, the behavior of immortalized hASCs in basal medium was also investigated. Both hTERT/ SV40 (TS) and hTERT/HPV E6/E7 (TE) co-transductions successfully immortalized hASCs. hASCs-TS and hASCs-TE reached elevated Population Doubling Levels (up to 100) and were expanded to obtain elevated cell number. Flow cytometry showed that both hASCs-TS and hASCs-TE retained a mesenchymal phenotypic profile while differentiation potential decreased particularly in hASCs-TS. Of note, the levels of HGF and VEGF secreted by hASCs-TS and hASCs-TE remained elevated after immortalization. Finally, both hASCs-TS and hASCs-TE were successfully cultured in basal medium without FBS and or exogenous recombinant proteins. We have developed a “hybridoma-like model” that by coupling hASCs immortalization and their paracrine characteristics may have potential application in discovering and producing molecules to use in regenerative medicine (process scale-up). Moreover, such model may be very useful to eliminate direct injection of cells thus avoiding potential adverse effects.

Subjects

Engineering

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Regenerative Medicine.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Regenerative Medicine
  • SubjectEngineering
  • BylineArticles whose byline prints “Luigi Balducci”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels